Sodium phosphate dihydrate, monobasic

Anhydrous monobasic sodium phosphate [7558-80-7] Monobasic sodium phosphate monohydrate [10049-21-5] Monobasic sodium phosphate dihydrate [13472-35-0]... 

One gram of monobasic sodium phosphate dihydrate represents approximately 6.4 mmol of sodium and of phosphate. 

Each syringe deiivers 0.8 ml (40 mg) of DP. Each vial contains approximately 0.9 mL of solution to deiiver 0.8 ml (40 mg) of DP. Each 0.8 ml contains 40 mg of adaiimumab, 4.93 mg of sodium chioride, 0.69 mg of monobasic sodium phosphate dihydrate, 1.22 mg of dibasic sodium phosphate dihydrate, 0.24 mg of sodium citrate, 1.04 mg of citric acid monohydrate, 9.6 mg of mannitol, 0.8 mg of polysorbate 80 and water for injection, USP. Sodium hydroxide added as necessary to adjust pH. 

Each vial contains either 74, 118.4, 177.6, or 222 p.g of PEG-intron, and 1.11 mg of dibasic sodium phosphate anhydrous, 1.11 mg of monobasic sodium phosphate dihydrate, 59.2 mg of sucrose, and 0.074 mg of polysorbate 80. Following reconstitution with 0.7 mL of the supplied diluent (SWFI, USP), each vial contains peginterferon at strengths of either 100, 160, 240, or 300 p,g/mL. 

To be reconstituted with sterile WFI (pH approximately 7.2) Per lOmL 500 mg sucrose 0.5 mg polysorbate 80 2.2 mg monobasic sodium phosphate monohydrate 6.1 mg dibasic sodium phosphate dihydrate IV infusion... 

Monobasic sodium phosphate is chemically stable, although it is slightly deliquescent. On heating at 100°C, the dihydrate loses all of its water of crystallization. On further heating, it melts with decomposition at 205°C, forming sodium hydrogen pyrophosphate, Na2H2P20y. At 250°C it leaves a final residue of sodium metaphosphate, NaPOs. 

Avastin Avastin is used for the treatment of colorectal cancer. It is supplied in 100 and 400 mg dosages. The 100 mg formulation consists of 240 mg a,a-trehalose dihydrate, 23.2 mg sodium phosphate (monobasic, monohydrate), 4.8mg sodium phosphate (dibasic, anhydrous), 1.6mg polysorbate 20 and water-for-injection. 

PEG-Intron PEG-Intron is used for the treatment of hepatitis C. The product consists of a covalent conjugate of the recombinant interferon- -2b with monomethoxy polyethylene glycol (PEG) supplied in vials with 74/rg, 118.4/rg, 177.6/rg, or 222/rg of the active ingredient and 1.11 mg sodium phosphate (dibasic,anhydrous),l.ll mg sodium phosphate (monobasic, dihydrate), 59.2 mg sucrose, and 0.074mg polysorbate 80. The powder is reconstituted with sterile water-for-injection. 

Pre filled syringe polysorbate-80 containing (HSA- free) formulation glycine polysorbate 80 sodium chloride sodium phosphate monobasic dihydrate sodium phosphate dibasic dihydrate water for injection... 

Calcium phosphate monobasic monohydrate Sodium fluoride Sodium phosphate dibasic dihydrate... 

Calcium phosphate monobasic anhydrous Choline bitartrate Cobalt diacetate Sodium phosphate dibasic dihydrate mineral supplement, animal feed Calcium phosphate dibasic Ferrous sulfate monohydrate... 

NaH2P04.2H20 Sodium dihydrogen phosphate dihydrate Sodium phosphate, monobasic... 

Cyclohexane was purchased from Sigma-Aldrich that was used as an organic solvent and surfactant of Triton X-45 (Sigma-Aldrich) was selected. Tetrapropyl orthotitanate (Ti(OC3Hv)4) from Fluka and sodium hydroxide ( HmbG chemical ) were used. Buffer at pH 7 was prepared with Sodium Phosphate Monobasic Dihydrate (H2Na04P.2H20) from Fluka, assay 99.0 % and Sodium Phosphate... 

---